Skip to content

HYFT

MindWalk Holdings Corp.

NASDAQ · Healthcare · Biotechnology · CA

$1.36
+3.82%
Ask drillr

Year over year

Reported trailing growth

Revenue
-14.9%
EBITDA
+44.6%
EBIT
-29.6%
EPS
+59.7%
Free cash flow
-31.1%
Operating cash flow
-41.0%

Forward estimates

Based on analyst estimates

Revenue
-11.1%
EBITDA
+28.8%
EPS
+25.9%

Three-year CAGR

Revenue
-9.5%
EBITDA
+54.5%
EBIT
-20.6%
Net income
+54.6%
EPS
+66.7%
Free cash flow
-75.7%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026